4//SEC Filing
Louria Hayon Igal 4
Accession 0001213900-23-019554
CIK 0001415397other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:02 PM ET
Size
5.2 KB
Accession
0001213900-23-019554
Insider Transaction Report
Form 4
Louria Hayon Igal
DirectorChief Technology Officer
Transactions
- Award
Warrants to Purchase Common Stock
2022-12-05+999,000→ 990,000 totalExercise: $0.01Exp: 2024-07-05→ Common Stock (990,000 underlying)
Footnotes (1)
- [F1]The warrants are exercisable immediately.
Documents
Issuer
Raphael Pharmaceutical Inc.
CIK 0001415397
Entity typeother
Related Parties
1- filerCIK 0001903781
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:02 PM ET
- Size
- 5.2 KB